Skip to main content

Advertisement

Log in

Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

It is well established that both estrogen loss and type II diabetes mellitus (DMII) can impair bone metabolism, but whether estrogen loss exacerbates the effects of DMII is unclear. Therefore, we determined if ovariectomy (OVX) of rats on a long-term high-fat/sugar diet and injection of a low dose of streptozotocin (DMII) decreased bone mineral density (BMD) more than OVX or DMII alone. Bone insulin signaling is known to support bone metabolism; therefore, we also tested the hypothesis that OVX DMII rats (DOVX) would exhibit greater reductions in the expression of proteins important in insulin signaling, including IRS-1, IRS-2, and IGF-1. As hypothesized, BMD and plasma estrogen levels were decreased more in DOVX rats than in rats following OVX (NOVX) or DMII (DS) alone. IGF-1 expression was decreased in the liver, kidney, skeletal muscle, and bone of DOVX, DS, and NOVX rats; however, the decrease was larger and occurred sooner in DOVX rats. While IRS-1 and IRS-2 decreased in most groups in all tissues examined, the expression patterns differed in both a group- and tissue-dependent fashion. In conclusion, these data demonstrate that estrogen loss and DMII induced by a high-fat/sugar diet interact to produce osteoporosis and support the hypothesis that the bone loss may be mediated at least in part by concurrent decreases in the insulin signaling proteins in bone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. M. Prasannarong, K. Vichaiwong, V. Saengsirisuwan, Calorie restriction prevents the development of insulin resistance and impaired insulin signaling in skeletal muscle of ovariectomized rats. Biochim. Biophys. Acta 1822, 1051–1061 (2012)

    Article  PubMed  CAS  Google Scholar 

  2. D. Unal, S. Aksak, Z. Halici, O. Sengul, B. Polat, B. Unal, M. Halici, Effects of diabetes mellitus on the rat liver during the postmenopausal period. J. Mol. Histol. 42, 273–287 (2011)

    Article  PubMed  CAS  Google Scholar 

  3. H. Chang-Quan, D. Bi-Rong, H. Ping, L. Zhen-Chan, Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus. J. Bone. Miner. Metab. 26, 561–568 (2008)

    Article  PubMed  Google Scholar 

  4. S. Elis, H.W. Courtland, Y. Wu, J.C. Fritton, H. Sun, C.J. Rosen, S. Yakar, Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. J. Bone. Miner. Res. 25, 2051–2058 (2010)

    Article  PubMed  CAS  Google Scholar 

  5. R. Blakytny, M. Spraul, E.B. Jude, Review: the diabetic bone: a cellular and molecular perspective. Int. J. Low. Extrem. Wounds 10, 16–32 (2011)

    Article  PubMed  Google Scholar 

  6. T.D. Rachner, S. Khosla, L.C. Hofbauer, Osteoporosis: now and the future. Lancet 377, 1276–1287 (2011)

    Article  PubMed  CAS  Google Scholar 

  7. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)

    Article  PubMed  CAS  Google Scholar 

  8. F.J. de Paula, M.C. Horowitz, C.J. Rosen, Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab. Res. Rev. 26, 622–630 (2010)

    Article  PubMed  Google Scholar 

  9. S. Kurra, E. Siris, Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab. Res. Rev. 27, 430–435 (2011)

    Article  PubMed  Google Scholar 

  10. C. Torti, G. Mazziotti, P.A. Soldini, E. Focà, R. Maroldi, D. Gotti, G. Carosi, A. Giustina, High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine 41, 512–517 (2012)

    Article  PubMed  CAS  Google Scholar 

  11. S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, S. Miccoli, A. Ciampolillo, A. Corrado, F.P. Cantatore, R. Giorgino, F. Giorgino, Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis. Endocrinology 149, 1302–1313 (2008)

    Article  PubMed  CAS  Google Scholar 

  12. A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)

    Article  PubMed  CAS  Google Scholar 

  13. J. Paccou, J. Dewailly, B. Cortet, Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine 79, 78–82 (2012)

    Article  PubMed  CAS  Google Scholar 

  14. J. Vangipurapu, A. Stančáková, T. Kuulasmaa, P. Soininen, A.J. Kangas, M. Ala-Korpela, J. Kuusisto, M. Laakso, Association between liver insulin resistance and cardiovascular risk factors. J. Intern. Med. (2012). doi:10.1111/j.1365-2796.2012.02540.x

    PubMed  Google Scholar 

  15. R.A. Soslow, A.J. Dannenberg, D. Rush, B.M. Woerner, K.N. Khan, J. Masferrer, A.T. Koki, COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89, 2637–2645 (2000)

    Article  PubMed  CAS  Google Scholar 

  16. R.R. Bosch, S.W. Janssen, P.N. Span, A. Olthaar, S.E. van Emst-de Vries, P.H. Willems, J.M.G. Martens, A.R. Hermus, C.C. Sweep, Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker diabetic fatty rats. Endocrine 20, 247–252 (2003)

    Article  PubMed  CAS  Google Scholar 

  17. M. Mansour, D. White, C. Wernette, J. Dennis, Y.X. Tao, R. Collins, L. Parker, E. Morrison, Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor. Endocrine 37, 220–230 (2010)

    Article  PubMed  CAS  Google Scholar 

  18. M.H. Giroix, K. Louchami, Y.A. Carpentier, A. Sener, W.J. Malaisse, Fatty acid pattern of pancreatic islet lipids in Goto–Kakizaki rats. Endocrine 37, 173–179 (2010)

    Article  PubMed  CAS  Google Scholar 

  19. M. Matsushita, K. Tamura, S. Osada, H. Kogo, Effect of troglitazone on the excess testosterone and LH secretion in thyroidectomized, insulin-resistant, type 2 diabetic Goto–Kakizaki rats. Endocrine 27, 301–305 (2005)

    Article  PubMed  CAS  Google Scholar 

  20. M.S. Islam, T. Loots du, Experimental rodent models of type 2 diabetes: a review. Methods Find. Exp. Clin. Pharmacol. 31, 249–261 (2009)

    PubMed  CAS  Google Scholar 

  21. M. Yu, W. Zhou, Y. Song, F. Yu, D. Li, S. Na, G. Zou, M. Zhai, C. Xie, Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model. Bone 49, 387–394 (2011)

    Article  PubMed  CAS  Google Scholar 

  22. K. Srinivasan, B. Viswanad, L. Asrat, C.L. Kaul, P. Ramarao, Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52, 313–320 (2005)

    Article  PubMed  CAS  Google Scholar 

  23. M.J. Reed, K. Meszaros, L.J. Entes, M.D. Claypool, J.G. Pinkett, T.M. Gadbois, G.M. Reaven, A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390–1394 (2000)

    Article  PubMed  CAS  Google Scholar 

  24. W. Sun, Y. Bi, H. Liang, M. Cai, X. Chen, Y. Zhu, M. Li, F. Xu, Q. Yu, X. He, J. Ye, J. Weng, Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats. Endocrine 39, 235–241 (2011)

    Article  PubMed  CAS  Google Scholar 

  25. D. Merlotti, L. Gennari, F. Dotta, D. Lauro, R. Nuti, Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 20, 683–690 (2010)

    Article  PubMed  CAS  Google Scholar 

  26. R.A. Kayal, J. Alblowi, E. McKenzie, N. Krothapalli, L. Silkman, L. Gerstenfeld, T.A. Einhorn, D.T. Graves, Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 44, 357–363 (2009)

    Article  PubMed  CAS  Google Scholar 

  27. A. Montagnani, S. Gonnelli, M. Alessandri, R. Nuti, Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin. Exp. Res. 23, 84–90 (2011)

    PubMed  Google Scholar 

  28. J.M. Pritchard, L.M. Giangregorio, S.A. Atkinson, K.A. Beattie, D. Inglis, G. Ioannidis, Z. Punthakee, J.D. Adachi, A. Papaioannou, Adults with type 2 diabetes mellitus (DM) have an elevated fracture risk despite normal areal bone mineral density (aBMD). Arthr. Care Res. (Hoboken) 64, 83–91 (2012)

    Article  Google Scholar 

  29. T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45, 784–788 (2009)

    Article  PubMed  CAS  Google Scholar 

  30. G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40, 102–108 (2011)

    Article  PubMed  CAS  Google Scholar 

  31. A. Shu, M.T. Yin, E. Stein, S. Cremers, E. Dworakowski, R. Ives, M.R. Rubin, Bone structure and turnover in type 2 diabetes mellitus. Osteoporos. Int. 23, 635–641 (2012)

    Article  PubMed  CAS  Google Scholar 

  32. C. Hamann, C. Goettsch, J. Mettelsiefen, V. Henkenjohann, M. Rauner, U. Hempel, R. Bernhardt, N. Fratzl-Zelman, P. Roschger, S. Rammelt, K.P. Günther, L.C. Hofbauer, Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am. J. Physiol. Endocrinol. Metab. 301, E1220–E1228 (2011)

    Article  PubMed  CAS  Google Scholar 

  33. N. Erdal, S. Gürgül, S. Kavak, A. Yildiz, M. Emre, Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats. Biol. Trace Elem. Res. 140, 342–353 (2011)

    Article  PubMed  CAS  Google Scholar 

  34. S. Chakreeyarat, S. Saetung, L.O. Chailurkit, S. Rattanasiri, S. Ditbanjong, N. Chitrapazt, S. Jaovisidha, B. Ongphiphadhanakul, Elevated vitamin D status in postmenopausal women on thiazolidinediones for type 2 diabetes. Endocrine 39, 278–282 (2011)

    Article  PubMed  CAS  Google Scholar 

  35. M. Yamamoto, T. Yamaguchi, K. Nawata, M. Yamauchi, T. Sugimoto, Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J. Clin. Endocrinol. Metab. 97, 1277–1284 (2012)

    Article  PubMed  CAS  Google Scholar 

  36. L. Sauque-Reyna, M.A. Salcedo-Parra, P.R. Sánchez-Vargas, J.D. Flores-Helguera, C. Badillo-Sánchez, A. Reza-Albarrán, M. Rodríguez-Morán, F. Guerrero-Romero, Bone mineral density in patients with type 2 diabetes. Rev. Invest. Clin. 63, 162–169 (2011)

    PubMed  Google Scholar 

  37. S. Arikan, A. Tuzcu, M. Bahceci, S. Ozmen, D. Gokalp, Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. J. Clin. Densitom. 15, 186–190 (2012)

    Article  PubMed  Google Scholar 

  38. N. Ogata, H. Kawaguchi, Involvement of insulin and IGF-1 signaling molecules in bone metabolism. Clin. Calcium 18, 614–622 (2008)

    PubMed  CAS  Google Scholar 

  39. T. Akune, N. Ogata, K. Hoshi, N. Kubota, Y. Terauchi, K. Tobe, H. Takagi, Y. Azuma, T. Kadowaki, K. Nakamura, H. Kawaguchi, Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J. Cell. Biol. 159, 147–156 (2002)

    Article  PubMed  CAS  Google Scholar 

  40. W. Zhang, X. Shen, C. Wan, Q. Zhao, L. Zhang, Q. Zhou, L. Deng, Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell. Biochem. Funct. 30, 297–302 (2012)

    Article  PubMed  CAS  Google Scholar 

  41. M. Cipok, S. Aga-Mizrachi, A. Bak, T. Feurstein, R. Steinhart, C. Brodie, S.R. Sampson, Protein kinase Calpha regulates insulin receptor signaling in skeletal muscle. Biochem. Biophys. Res. Commun. 345, 817–824 (2006)

    Article  PubMed  CAS  Google Scholar 

  42. M.K. Diamond-Stanic, E.M. Marchionne, Critical role of the transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress. Biochem. Biophys. Res. Commun. 405, 439–444 (2011)

    Article  PubMed  CAS  Google Scholar 

  43. Y. Segev, R. Eshet, O. Yakir, N. Haim, M. Phillip, D. Landau, Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes. Diabetologia 50, 1327–1334 (2007)

    Article  PubMed  CAS  Google Scholar 

  44. J.L. Bailey, B. Zheng, Z. Hu, S.R. Price, W.E. Mitch, Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J. Am. Soc. Nephrol. 17, 1388–1394 (2006)

    Article  PubMed  CAS  Google Scholar 

  45. V.T. Samuel, G.I. Shulman, Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852–871 (2012)

    Article  PubMed  CAS  Google Scholar 

  46. Y. Zhang, B. Zhou, F. Zhang, J. Wu, Y. Hu, Y. Liu, Q. Zhai, Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61, 1434–1443 (2012)

    Article  PubMed  CAS  Google Scholar 

  47. O.T. Hardy, M.P. Czech, S. Corvera, What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes Obes. 19, 81–87 (2012)

    PubMed  CAS  Google Scholar 

  48. A.R. Martins, R.T. Nachbar, R. Gorjao, M.A. Vinolo, W.T. Festuccia, R.H. Lambertucci, M.F. Cury-Boaventura, L.R. Silveira, R. Curi, S.M. Hirabara, Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis. 11, 30 (2012)

    Article  PubMed  CAS  Google Scholar 

  49. S.S. Moon, Y.S. Lee, S.W. Kim, Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine (2012). doi:10.1007/s12020-012-9639-6

  50. D.C. Leitman, S. Paruthiyil, C. Yuan, C.B. Herber, M. Olshansky, M. Tagliaferri, I. Cohen, T.P. Speed, Tissue-specific regulation of genes by estrogen receptors. Semin. Reprod. Med. 30, 14–22 (2012)

    Article  PubMed  CAS  Google Scholar 

  51. A. Margoni, L. Fotis, A.G. Papavassiliou, The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis. Int. J. Biochem. Cell. Biol. 44, 475–479 (2012)

    Article  PubMed  CAS  Google Scholar 

  52. P. Magni, E. Dozio, E. Galliera, M. Ruscica, M.M. Corsi, Molecular aspects of adipokine-bone interactions. Curr. Mol. Med. 10, 522–532 (2010)

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Professor Virginia L. Brooks for editing the language (Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97239, USA. brooksv@ohsu.edu). This study was financially supported by Hebei Natural Science Foundation (C2009001179).

Conflict of interest

None of the authors has any conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukun Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, B., Wang, Y., Liu, Y. et al. Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine 43, 136–146 (2013). https://doi.org/10.1007/s12020-012-9757-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9757-1

Keywords

Navigation